Demo Sign up Log In

Regeneron Pharmaceuticals (REGN)

Financing Cash Flow

-$4.65B

TTM · Period ending: Jun 30, 2026 · USD

REGN Financing Cash Flow

Latest reported-$4.65Bperiod endingJun 30, 2026

Latest reported-$4.65Bperiod endingJun 30, 2026

REGN TTM Cash from Financing (-$800.00K → -$4.65B)

TTM financing cash flow

High-resolution chart · PNG

REGN financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period ending	Financing Cash Flow (USD)
Jun 30, 2001	174,836,000
Mar 31, 2001	244,344,000
Dec 31, 2000	92,867,000
Sep 30, 2000	93,228,000
Jun 30, 2000	75,373,000
Mar 31, 2000	2,375,000
Dec 31, 1999	300,000
Sep 30, 1999	-200,000
Jun 30, 1999	-200,000
Mar 31, 1999	-300,000
Dec 31, 1998	-1,400,000
Sep 30, 1998	-2,200,000
Jun 30, 1998	-2,600,000
Mar 31, 1998	39,900,000
Dec 31, 1997	39,400,000
Sep 30, 1997	50,000,000
Jun 30, 1997	49,800,000
Mar 31, 1997	65,100,000
Dec 31, 1996	66,300,000
Sep 30, 1996	78,600,000
Jun 30, 1996	78,800,000
Mar 31, 1996	20,600,000
Dec 31, 1995	19,900,000
Sep 30, 1995	-400,000
Jun 30, 1995	-400,000
Mar 31, 1995	-500,000
Dec 31, 1994	-200,000
Sep 30, 1994	-2,300,000
Jun 30, 1994	49,400,000
Mar 31, 1994	49,900,000
Dec 31, 1993	49,800,000
Sep 30, 1993	50,200,000
Jun 30, 1993	-1,100,000
Mar 31, 1993	-1,000,000
Dec 31, 1992	-800,000
Sep 30, 1992	-700,000
Jun 30, 1992	-400,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.